Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 9Recruiting 3Terminated 2Unknown 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3Myeloid 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Burkitt Lymphoma 17Lymphoma, Large B-Cell, Diffuse 12Neuroblastoma 7Lymphoma, Follicular 7Lymphoma, B-Cell 7Leukemia, Biphenotypic, Acute 7Rhabdomyosarcoma 6Lymphoma, T-Cell, Peripheral 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Sarcoma, Ewing 4Lymphoma 4Retinoblastoma 3Recurrence 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Osteosarcoma 3Medulloblastoma 3Lymphoma, T-Cell 3Lymphoma, Non-Hodgkin 3Wilms Tumor 2Sarcoma 2Plasmablastic Lymphoma 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, B-Cell 2Hodgkin Disease 2Ganglioneuroblastoma 2Blastic Plasmacytoid Dendritic Cell Neoplasm 2Stage I Mixed Cell Type Kidney Wilms Tumor 1Rhabdomyosarcoma, Embryonal 1Rhabdoid Tumor 1

Interventions

Cyclophosphamide 7Biopsy 6fludarabine 5Specimen Handling 5Magnetic Resonance Spectroscopy 5ruxolitinib 3X-Rays 3Whole-Body Irradiation 3Vincristine 3Peripheral Blood Stem Cell Transplantation 3Cytarabine 310-propargyl-10-deazaaminopterin 3sodium-iodide symporter 2pembrolizumab 2cemiplimab 2Photons 2Methotrexate 2Ipilimumab 2Immunoglobulin G 2Hydrocortisone 2Etoposide 2Disulfides 2Dexamethasone 2Calcium Dobesilate 2CTLA-4 Antigen 2Azacitidine 2venetoclax 1tagraxofusp 1romidepsin 1nelarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Lymphoma, T-Cell × Vincristine × Clear all
NCT06390319 2026-05-01

Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

St. Jude Children's Research Hospital

Phase 2 Recruiting
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Lymphoma, T-Cell, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05996185 2026-04-14

Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma

Yale University

Phase 2 Recruiting
22 enrolled
DermatologicLymphoidOther hematologic neoplasm

Recurrence, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05476770 2024-12-06

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1 Recruiting
54 enrolled
LymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Hodgkin Disease, Leukemia, Biphenotypic, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡